Laser Cap Side Effects & Safety
The short version
- What the studies report: the trials we read reported no serious adverse events. The effects named were dry skin (5.1% in one trial), itching, scalp tenderness, irritation, a warm sensation and, in another trial, temporary hair shedding. A pooled analysis of 11 sham-controlled trials favoured laser therapy over sham for hair density.
- Who must not use the 272: pregnant women, children, those with heart disease and those who have undergone brain surgery. For other contraindications, consult your doctor. An omitted condition is not a safety clearance.
- Class 3R laser equipment: do not look directly at the light source output window, and prevent direct eye exposure.
- The 272 routine: 30 minutes, 2–3 times a week, on non-consecutive days, at any time of day.
What the studies report
"Well tolerated" is the usual one-line summary. Here is what the papers actually counted.
| Study | Who and how many | Device and length | What it reports on adverse events | Paid for by |
|---|---|---|---|---|
| Lanzafame 2013 | 44 men recruited (Fitzpatrick I–IV, Norwood-Hamilton IIa–V); 41 completed, 22 on the device and 19 on sham | Helmet-style device with 21 lasers and 30 LEDs, every other day for 16 weeks | No adverse events or side effects reported | Device maker (registry sponsor) |
| Leavitt 2009 | Men with Norwood-Hamilton IIa–V loss, randomised 2:1 to device or sham; 110 completed | Hand-held Class 3R laser comb, 26 weeks | Well tolerated; no serious adverse events; no statistical difference in adverse effects between groups. Event counts not reported in the sources read | Device maker |
| Jimenez 2014 | 269 randomised (128 men, 141 women) across four trials of three comb models; 225 in the efficacy analysis | Hand-held laser comb, three times a week for 26 weeks | No serious adverse events in anyone using the comb. Laser-comb-related events, percentages as reported: dry skin 5.1%, pruritus 2.5%, scalp tenderness 1.3%, irritation 1.3%, warm sensation 1.3%. None led to stopping the device or interrupting the study. Counts behind the percentages not given | Device maker (partly funded the study and supplied the devices) |
| Kim 2013 | 40 enrolled | Helmet-type device, 18 minutes every day for 24 weeks | No serious adverse reactions detected. Counts not reported in the sources read | Not reported in the sources read |
| Suchonwanit 2019 | 40 randomised (20 men, 20 women); 36 completed, 19 on the device and 17 on sham | Helmet-type device, 24 weeks | Temporary hair shedding and scalp itching (pruritus) reported. Counts not reported in the sources read | The investigators' own institute built the device |
| Yoon 2020 | 60 randomised at 2 institutions; all showed good compliance | Helmet-type device, 25 minutes every other day for 16 weeks | No adverse events or side effects occurred over the 16 weeks | Device maker |
| Liu 2019 meta-analysis | 8 studies, 11 sham-controlled randomised trials, in adults | Pooled laser therapy trials | The pooled result favoured laser therapy over sham for hair density (standardised mean difference 1.316, 95% CI 0.993 to 1.639); adverse events not reported in the sources read. The authors note differences between the included trials | Government research grant (Taiwan Ministry of Science and Technology) |
Across these reports, no serious adverse events were described, and the effects that were named are the ones listed above. That is a description of these trials, not a promise about any cap. They ran 16 to 26 weeks and enrolled between 40 and 269 people, so they speak to the first months of use, and individual results vary.
How LLLT works → · Our table of every randomised trial →
Who must not use the Luxuel Laser Cap 272?
The following people are prohibited from using this device:
- Pregnant women
- Children
- Those with heart disease
- Those who have undergone brain surgery
For other contraindications please consult your doctor.
These are the exclusions in the manufacturer's instruction leaflet dated 30 March 2026. An omitted condition is not a personal safety clearance. Ask your doctor about other contraindications and about the cause of your hair loss.
What are the laser precautions?
Do not look directly at the light source output window. Do not look directly at the beam or view it through optical instruments. Do not point the laser beam at others. The 272 is Class 3R laser equipment: visible light radiation, so prevent direct eye exposure, and do not look directly at the emitter because of the strong light intensity.
What precautions apply to care and storage?
Store and use the product at room temperature. Do not expose it to rain or humid environments. Avoid drops, temperatures above 60°C and fire. Do not disassemble, repair or modify it yourself. Do not use chemical solvents to wipe it. If it will not be used for an extended period, clean it and store it in a dry place. The leaflet gives no cleaning method; ask support for guidance.
What side effects does the leaflet describe?
The leaflet does not provide an adverse-effect list or a symptom-duration rule. It says effects may vary between individuals. Do not use warmth, tingling or visible glow as proof that treatment is working. Ask your healthcare professional about symptoms or suitability, and contact support about device problems.
Does this establish compatibility with minoxidil or other treatments?
No. The leaflet does not establish compatibility with any medicine or other treatment. Your doctor is the right person to ask about your specific combination.
What is the routine?
30 minutes, 2–3 times a week, on non-consecutive days, at any time of day. The 272 manual says not to use it more than once a day and to continue at the same rhythm after the recommended 10–12 week course. Non-consecutive days and the same-rhythm instruction are Luxuel's guidance, distinct from the leaflet's treatment-time line. Frequency and dose →
Is it safe long-term?
The studies above ran 16 to 26 weeks. The 272's recommended course is about 10–12 weeks, and the manual says to continue at the same rhythm afterwards. If you have a health concern about longer use, ask your doctor. What to expect over time →
The honest framing
"Well tolerated" is not the same as "risk-free for everyone", and nothing on this page replaces your doctor. The device's cleared indication is androgenic alopecia in men at Norwood-Hamilton IIa–V or women at Ludwig-Savin I–II, both with Fitzpatrick skin types I–IV. The Luxuel Laser Cap 272 is FDA 510(k) cleared (K261253) for hair growth, and the cautions above are the honest fine print. Individual results vary. Setup, care and warranty → · See the cap →
The Luxuel Laser Cap 272
272 × 650nm laser diodes · FDA 510(k) cleared (K261253) · $899
See the 272 →Not intended to diagnose, treat, cure, or prevent any disease. The clinical studies referenced evaluated a clinically studied 650nm wavelength and the low-level laser therapy category broadly. Individual results vary and depend on consistent use over time. The FDA 510(k) clearance (K261253) is held by the manufacturer.
